Proteon Pharma to Focus on Development of Bacteriophages as a Sustainable Alternative to Antibiotics in Poultry Industry


Mumbai, Maharashtra, India


Proteon Pharmaceuticals India – a subsidiary of Proteon Pharmaceuticals SA Poland, today announced it will focus on the development of bacteriophages as a sustainable alternative to antibiotics in the poultry industry. It is engaged in the development of precision biology for microbiome protection to improve animal and human health and eliminating the unnecessary use of antibiotics.


 


Elaborating on Proteon Pharmaceuticals product development strategy, Dr. Ramdas Kambale, Director, Sales, Asia Pacific said, “Antibiotics usage

Continue Reading